Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 02/9/15 → 10/10/19 |
Funding
- National Cancer Institute: $9.00
Alliance: A Randomized Phase III Study of Bendamustine Plus Rituximab Versus Ibrutinib Plus Rituximab Versus Ibrutinib Alone in Untreated Older Patients (>65 Years of Age) With Chronic Lymphocytic Leukemia (CLL)
- Gabig, Theodore (CoPI)
- Lan, Fengshuo (CoPI)
- Schuster, Michael (CoPI)
- Kiner-Strachan, Bonnie (PI)
Project: Research